AngioDynamics Inc specializes in the development manufacturing and commercialization of a diverse array of medical surgical and diagnostic instruments These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease facilitate vascular access and support various oncology and surgical interventions serving both domestic and international markets The companys portfolio includes advanced ablation systems like NanoKnife designed for the precise surgical removal of soft tissues and Solero microwave and radiofrequency systems effective in ablating solid cancerous or benign growths Additionally they provide BioSentry tract sealant systems IsoLoc Endorectal Balloons Alatus vaginal balloon packing systems angiographic catheters guidewires percutaneous drainage catheters and coaxial microintroducer kits Their endovascular therapies segment encompasses solutions for thrombus management atherectomy procedures core peripheral products and the treatment of venous insufficiency Furthermore AngioDynamics is a key supplier of vascular access devices such as peripherally inserted central catheters PICCs midline catheters implantable ports and dialysis catheters along with associated accessories These are primarily employed for shortduration systemic drug delivery including chemotherapy and antibiotics marketed under a robust portfolio of brand names such as BioFlo BioFlo Midline BioFlo PICC Xcela PICC PASV BioFlo Port SmartPort Vortex LifeGuard BioFlo DuraMax and DuraMax The company distributes its offerings directly to a specialized clientele including interventional radiologists cardiologists vascular surgeons urologists interventional and surgical oncologists and critical care nurses while also leveraging established distributor networks Founded in 1988 AngioDynamics maintains its corporate headquarters in Latham New York
Recent Earnings Surprises
Date
Actual EPS
Estimated EPS
Surprise
2026-04-02
$-0.07
$-0.11
+-36.4%
2026-01-06
$-0.15
$-0.10
50.0%
2025-10-02
$-0.10
$-0.14
+-28.6%
2025-07-15
$-0.03
$-0.13
+-76.9%
Financial Ratios (TTM)
Gross Margin
53.45%
Operating Margin
-8.08%
Net Margin
-10.00%
ROA
-12.04%
Price to Book
3.22
Price to Sales
1.76
Valoramos tu privacidad
Usamos cookies para analizar el tráfico y mostrar anuncios. Acepta todas las cookies o continúa solo con las esenciales. Más información